| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 1.68e-04 | 30 | 13 | 2 | GO:0004693 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 1.68e-04 | 30 | 13 | 2 | GO:0070577 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 1.68e-04 | 30 | 13 | 2 | GO:0097472 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 1.80e-04 | 31 | 13 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 2.68e-03 | 446 | 13 | 3 | GO:0004674 | |
| GeneOntologyMolecularFunction | protein kinase activity | 6.16e-03 | 600 | 13 | 3 | GO:0004672 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 7.67e-03 | 206 | 13 | 2 | GO:0140030 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 9.77e-03 | 709 | 13 | 3 | GO:0016773 | |
| GeneOntologyMolecularFunction | kinase activity | 1.20e-02 | 764 | 13 | 3 | GO:0016301 | |
| GeneOntologyMolecularFunction | histone binding | 1.24e-02 | 265 | 13 | 2 | GO:0042393 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid cohesion, centromeric | 8.97e-06 | 7 | 14 | 2 | GO:0071962 | |
| GeneOntologyBiologicalProcess | centromeric sister chromatid cohesion | 3.88e-05 | 14 | 14 | 2 | GO:0070601 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid cohesion | 2.66e-04 | 36 | 14 | 2 | GO:0007064 | |
| GeneOntologyBiologicalProcess | mRNA processing | 4.07e-04 | 551 | 14 | 4 | GO:0006397 | |
| GeneOntologyBiologicalProcess | rRNA transcription | 4.35e-04 | 46 | 14 | 2 | GO:0009303 | |
| GeneOntologyBiologicalProcess | regulation of centrosome cycle | 8.16e-04 | 63 | 14 | 2 | GO:0046605 | |
| GeneOntologyBiologicalProcess | sister chromatid cohesion | 9.22e-04 | 67 | 14 | 2 | GO:0007062 | |
| GeneOntologyBiologicalProcess | chromosome organization | 9.30e-04 | 686 | 14 | 4 | GO:0051276 | |
| GeneOntologyBiologicalProcess | embryo development | 1.92e-03 | 1437 | 14 | 5 | GO:0009790 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 2.60e-03 | 906 | 14 | 4 | GO:0043009 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 2.72e-03 | 917 | 14 | 4 | GO:0016071 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 2.85e-03 | 929 | 14 | 4 | GO:0009792 | |
| GeneOntologyCellularComponent | cyclin-dependent protein kinase holoenzyme complex | 7.45e-04 | 61 | 14 | 2 | GO:0000307 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 1.30e-03 | 335 | 14 | 3 | GO:0061695 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 1.49e-03 | 1377 | 14 | 5 | GO:0140513 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.83e-03 | 96 | 14 | 2 | GO:0070603 | |
| GeneOntologyCellularComponent | ATPase complex | 3.28e-03 | 129 | 14 | 2 | GO:1904949 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 4.81e-03 | 157 | 14 | 2 | GO:1902554 | |
| GeneOntologyCellularComponent | protein kinase complex | 5.61e-03 | 170 | 14 | 2 | GO:1902911 | |
| GeneOntologyCellularComponent | spliceosomal complex | 8.83e-03 | 215 | 14 | 2 | GO:0005681 | |
| MousePheno | increased skin papilloma incidence | 1.29e-04 | 22 | 11 | 2 | MP:0002051 | |
| MousePheno | increased papilloma incidence | 2.93e-04 | 33 | 11 | 2 | MP:0002014 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | 4.57e-04 | 203 | 11 | 3 | MP:0011094 | |
| MousePheno | increased skin tumor incidence | 5.47e-04 | 45 | 11 | 2 | MP:0010300 | |
| MousePheno | embryonic lethality before implantation | 7.63e-04 | 242 | 11 | 3 | MP:0006204 | |
| Domain | DUF3512 | 5.22e-07 | 2 | 14 | 2 | IPR021900 | |
| Domain | DUF3512 | 5.22e-07 | 2 | 14 | 2 | PF12024 | |
| Domain | BROMODOMAIN_1 | 3.42e-04 | 37 | 14 | 2 | PS00633 | |
| Domain | Bromodomain | 3.61e-04 | 38 | 14 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 4.21e-04 | 41 | 14 | 2 | PS50014 | |
| Domain | Bromodomain | 4.42e-04 | 42 | 14 | 2 | IPR001487 | |
| Domain | - | 4.42e-04 | 42 | 14 | 2 | 1.20.920.10 | |
| Domain | BROMO | 4.42e-04 | 42 | 14 | 2 | SM00297 | |
| Domain | Ank_2 | 1.10e-02 | 215 | 14 | 2 | PF12796 | |
| Domain | Ank | 1.23e-02 | 228 | 14 | 2 | PF00023 | |
| Domain | - | 1.44e-02 | 248 | 14 | 2 | 1.25.40.20 | |
| Domain | ANK | 1.47e-02 | 251 | 14 | 2 | SM00248 | |
| Domain | ANK_REPEAT | 1.49e-02 | 253 | 14 | 2 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 1.51e-02 | 254 | 14 | 2 | IPR020683 | |
| Domain | ANK_REP_REGION | 1.51e-02 | 254 | 14 | 2 | PS50297 | |
| Domain | Ankyrin_rpt | 1.60e-02 | 262 | 14 | 2 | IPR002110 | |
| Domain | Ser/Thr_kinase_AS | 2.85e-02 | 357 | 14 | 2 | IPR008271 | |
| Domain | S_TKc | 2.88e-02 | 359 | 14 | 2 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 2.92e-02 | 362 | 14 | 2 | PS00108 | |
| Domain | Pkinase | 3.21e-02 | 381 | 14 | 2 | PF00069 | |
| Pathway | BIOCARTA_HIVNEF_PATHWAY | 5.48e-04 | 56 | 9 | 2 | MM1406 | |
| Pathway | BIOCARTA_HIVNEF_PATHWAY | 5.48e-04 | 56 | 9 | 2 | M13968 | |
| Pathway | REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES | 1.14e-03 | 81 | 9 | 2 | M748 | |
| Pathway | WP_1P36_COPY_NUMBER_VARIATION_SYNDROME | 2.17e-03 | 112 | 9 | 2 | M48072 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 8.08e-10 | 954 | 14 | 8 | 36373674 | |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 5.04e-08 | 269 | 14 | 5 | 29511261 | |
| Pubmed | Regulated expression of a cell division control-related protein kinase during development. | 1.50e-07 | 2 | 14 | 2 | 2069872 | |
| Pubmed | A cyclin-dependent kinase homologue, p130PITSLRE is a phosphotyrosine-independent SH2 ligand. | 1.50e-07 | 2 | 14 | 2 | 7528743 | |
| Pubmed | Identification and characterization of a novel cell cycle-regulated internal ribosome entry site. | 1.50e-07 | 2 | 14 | 2 | 10882096 | |
| Pubmed | Protein expression pattern of CDK11(p58) during testicular development in the mouse. | 1.50e-07 | 2 | 14 | 2 | 15792358 | |
| Pubmed | 1.50e-07 | 2 | 14 | 2 | 15060143 | ||
| Pubmed | The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer. | 1.50e-07 | 2 | 14 | 2 | 27049727 | |
| Pubmed | CDK11p58 Promotes Microglia Activation via Inducing Cyclin D3 Nuclear Localization. | 1.50e-07 | 2 | 14 | 2 | 28101846 | |
| Pubmed | 1.50e-07 | 2 | 14 | 2 | 1774066 | ||
| Pubmed | 1.50e-07 | 2 | 14 | 2 | 36484504 | ||
| Pubmed | Molecular cloning and expression of alternatively spliced PITSLRE protein kinase isoforms. | 1.50e-07 | 2 | 14 | 2 | 8195233 | |
| Pubmed | 1.50e-07 | 2 | 14 | 2 | 30722725 | ||
| Pubmed | Structure and expression of the human p58clk-1 protein kinase chromosomal gene. | 1.50e-07 | 2 | 14 | 2 | 1639388 | |
| Pubmed | 1.50e-07 | 2 | 14 | 2 | 7920654 | ||
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 12624090 | ||
| Pubmed | Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice. | 4.51e-07 | 3 | 14 | 2 | 17389615 | |
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 33664748 | ||
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 19122208 | ||
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 9580558 | ||
| Pubmed | The cyclin-dependent kinase 11(p46) isoform interacts with RanBPM. | 4.51e-07 | 3 | 14 | 2 | 14511641 | |
| Pubmed | 9.02e-07 | 4 | 14 | 2 | 12501247 | ||
| Pubmed | 9.02e-07 | 4 | 14 | 2 | 24436071 | ||
| Pubmed | 9.02e-07 | 4 | 14 | 2 | 15330758 | ||
| Pubmed | Cyclin D3/CDK11p58 complex is involved in the repression of androgen receptor. | 9.02e-07 | 4 | 14 | 2 | 17698582 | |
| Pubmed | 9.02e-07 | 4 | 14 | 2 | 9115219 | ||
| Pubmed | Increased expression of a 58-kDa protein kinase leads to changes in the CHO cell cycle. | 9.02e-07 | 4 | 14 | 2 | 2217177 | |
| Pubmed | 9.02e-07 | 4 | 14 | 2 | 9750192 | ||
| Pubmed | A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. | 9.02e-07 | 4 | 14 | 2 | 7777541 | |
| Pubmed | Riz maps to distal chromosome 4 near genes involved in tumorigenesis and nerve degeneration. | 1.50e-06 | 5 | 14 | 2 | 8679000 | |
| Pubmed | 1.50e-06 | 5 | 14 | 2 | 9632733 | ||
| Pubmed | 1.50e-06 | 5 | 14 | 2 | 17516030 | ||
| Pubmed | The gene for mouse p58cdc2L1 (Cdc2l1) protein kinase maps to distal mouse chromosome 4. | 1.50e-06 | 5 | 14 | 2 | 8199413 | |
| Pubmed | 2.25e-06 | 6 | 14 | 2 | 19245811 | ||
| Pubmed | 2.25e-06 | 6 | 14 | 2 | 15963510 | ||
| Pubmed | The cyclin-dependent kinase 11 interacts with 14-3-3 proteins. | 3.16e-06 | 7 | 14 | 2 | 15883043 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 4.03e-06 | 283 | 14 | 4 | 30585729 | |
| Pubmed | Genomic organization and genetic mapping of the neuroimmune gene I2rf5 to mouse chromosome 4. | 4.21e-06 | 8 | 14 | 2 | 7774930 | |
| Pubmed | FBXL2 is a ubiquitin E3 ligase subunit that triggers mitotic arrest. | 4.21e-06 | 8 | 14 | 2 | 22024926 | |
| Pubmed | 5.41e-06 | 9 | 14 | 2 | 14623875 | ||
| Pubmed | 5.41e-06 | 9 | 14 | 2 | 15184363 | ||
| Pubmed | 9.23e-06 | 104 | 14 | 3 | 31365120 | ||
| Pubmed | 9.91e-06 | 12 | 14 | 2 | 19884882 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 1.16e-05 | 370 | 14 | 4 | 22922362 | |
| Pubmed | 1.40e-05 | 1497 | 14 | 6 | 31527615 | ||
| Pubmed | Kinome siRNA screen identifies regulators of ciliogenesis and hedgehog signal transduction. | 1.58e-05 | 15 | 14 | 2 | 18827223 | |
| Pubmed | 3.15e-05 | 21 | 14 | 2 | 12601173 | ||
| Pubmed | 3.15e-05 | 21 | 14 | 2 | 32731332 | ||
| Pubmed | 3.17e-05 | 157 | 14 | 3 | 30186101 | ||
| Pubmed | 3.35e-05 | 1014 | 14 | 5 | 32416067 | ||
| Pubmed | Positional cloning of the mouse saccharin preference (Sac) locus. | 3.46e-05 | 22 | 14 | 2 | 11555487 | |
| Pubmed | 6.07e-05 | 29 | 14 | 2 | 19279220 | ||
| Pubmed | 6.50e-05 | 30 | 14 | 2 | 31043422 | ||
| Pubmed | 7.41e-05 | 32 | 14 | 2 | 26142281 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 8.05e-05 | 608 | 14 | 4 | 36089195 | |
| Pubmed | Genetic mapping of the mouse ferritin light chain gene and 11 pseudogenes on 11 mouse chromosomes. | 9.41e-05 | 36 | 14 | 2 | 9457670 | |
| Pubmed | Identification of UHRF1/2 as new N-methylpurine DNA glycosylase-interacting proteins. | 1.05e-04 | 38 | 14 | 2 | 23537643 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 1.17e-04 | 1318 | 14 | 5 | 30463901 | |
| Pubmed | 1.19e-04 | 245 | 14 | 3 | 19521500 | ||
| Pubmed | 1.27e-04 | 251 | 14 | 3 | 31076518 | ||
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 1.93e-04 | 289 | 14 | 3 | 23752268 | |
| Pubmed | 2.21e-04 | 55 | 14 | 2 | 27114453 | ||
| Pubmed | CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11(p110). | 2.21e-04 | 55 | 14 | 2 | 23178491 | |
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 3.48e-04 | 69 | 14 | 2 | 28481362 | |
| Interaction | SMC5 interactions | 8.22e-08 | 1000 | 14 | 8 | int:SMC5 | |
| Interaction | NOLC1 interactions | 1.88e-06 | 325 | 14 | 5 | int:NOLC1 | |
| Interaction | ZC3H4 interactions | 2.57e-06 | 147 | 14 | 4 | int:ZC3H4 | |
| Interaction | ZRANB2 interactions | 8.55e-06 | 199 | 14 | 4 | int:ZRANB2 | |
| Interaction | JMJD6 interactions | 9.61e-06 | 205 | 14 | 4 | int:JMJD6 | |
| Interaction | POLR1G interactions | 1.38e-05 | 489 | 14 | 5 | int:POLR1G | |
| Interaction | ZCCHC10 interactions | 1.67e-05 | 236 | 14 | 4 | int:ZCCHC10 | |
| Interaction | NMT2 interactions | 1.82e-05 | 76 | 14 | 3 | int:NMT2 | |
| Interaction | DHX40 interactions | 2.07e-05 | 249 | 14 | 4 | int:DHX40 | |
| Interaction | LINC02910 interactions | 3.56e-05 | 95 | 14 | 3 | int:LINC02910 | |
| Interaction | RBM25 interactions | 5.71e-05 | 323 | 14 | 4 | int:RBM25 | |
| Interaction | GPATCH8 interactions | 6.29e-05 | 115 | 14 | 3 | int:GPATCH8 | |
| Interaction | DPF2 interactions | 7.71e-05 | 349 | 14 | 4 | int:DPF2 | |
| Interaction | PEX2 interactions | 9.34e-05 | 21 | 14 | 2 | int:PEX2 | |
| Interaction | CENPA interactions | 1.04e-04 | 377 | 14 | 4 | int:CENPA | |
| Interaction | H3-3A interactions | 1.06e-04 | 749 | 14 | 5 | int:H3-3A | |
| Interaction | PHF10 interactions | 1.11e-04 | 139 | 14 | 3 | int:PHF10 | |
| Interaction | CDC73 interactions | 1.14e-04 | 386 | 14 | 4 | int:CDC73 | |
| Interaction | KAT7 interactions | 1.44e-04 | 152 | 14 | 3 | int:KAT7 | |
| Interaction | RNPS1 interactions | 1.65e-04 | 425 | 14 | 4 | int:RNPS1 | |
| Interaction | FOXP3 interactions | 1.76e-04 | 432 | 14 | 4 | int:FOXP3 | |
| Interaction | MYCN interactions | 1.84e-04 | 1373 | 14 | 6 | int:MYCN | |
| Interaction | DDX41 interactions | 1.87e-04 | 166 | 14 | 3 | int:DDX41 | |
| Interaction | SUPT16H interactions | 1.92e-04 | 442 | 14 | 4 | int:SUPT16H | |
| Interaction | DDX55 interactions | 1.97e-04 | 169 | 14 | 3 | int:DDX55 | |
| Interaction | ZNF330 interactions | 1.99e-04 | 446 | 14 | 4 | int:ZNF330 | |
| Interaction | ECT2 interactions | 2.34e-04 | 887 | 14 | 5 | int:ECT2 | |
| Interaction | CDK11A interactions | 2.37e-04 | 180 | 14 | 3 | int:CDK11A | |
| Interaction | GPATCH2 interactions | 2.79e-04 | 36 | 14 | 2 | int:GPATCH2 | |
| Interaction | XRCC6 interactions | 2.89e-04 | 928 | 14 | 5 | int:XRCC6 | |
| Interaction | CSNK2A1 interactions | 3.32e-04 | 956 | 14 | 5 | int:CSNK2A1 | |
| Interaction | SPDEF interactions | 3.44e-04 | 40 | 14 | 2 | int:SPDEF | |
| Interaction | HECTD1 interactions | 3.80e-04 | 984 | 14 | 5 | int:HECTD1 | |
| Interaction | CASP3 interactions | 4.05e-04 | 216 | 14 | 3 | int:CASP3 | |
| Interaction | NUCKS1 interactions | 4.27e-04 | 220 | 14 | 3 | int:NUCKS1 | |
| Interaction | CTR9 interactions | 5.05e-04 | 233 | 14 | 3 | int:CTR9 | |
| Interaction | NOP56 interactions | 5.06e-04 | 570 | 14 | 4 | int:NOP56 | |
| Interaction | RBBP4 interactions | 5.16e-04 | 573 | 14 | 4 | int:RBBP4 | |
| Interaction | SKIC8 interactions | 5.44e-04 | 239 | 14 | 3 | int:SKIC8 | |
| Interaction | JADE3 interactions | 5.60e-04 | 51 | 14 | 2 | int:JADE3 | |
| Interaction | EIF3L interactions | 5.78e-04 | 244 | 14 | 3 | int:EIF3L | |
| Interaction | UQCR11 interactions | 6.05e-04 | 53 | 14 | 2 | int:UQCR11 | |
| Interaction | CFAP141 interactions | 6.52e-04 | 55 | 14 | 2 | int:CFAP141 | |
| Interaction | PBRM1 interactions | 6.80e-04 | 258 | 14 | 3 | int:PBRM1 | |
| Interaction | NUP43 interactions | 7.16e-04 | 625 | 14 | 4 | int:NUP43 | |
| Interaction | SIRT6 interactions | 7.29e-04 | 628 | 14 | 4 | int:SIRT6 | |
| Interaction | GEMIN5 interactions | 7.51e-04 | 267 | 14 | 3 | int:GEMIN5 | |
| Interaction | BRD7 interactions | 7.69e-04 | 637 | 14 | 4 | int:BRD7 | |
| Interaction | ARID1A interactions | 8.27e-04 | 276 | 14 | 3 | int:ARID1A | |
| Interaction | INTS8 interactions | 8.27e-04 | 62 | 14 | 2 | int:INTS8 | |
| Interaction | TMEM14B interactions | 8.53e-04 | 279 | 14 | 3 | int:TMEM14B | |
| Interaction | SLIT2 interactions | 8.54e-04 | 63 | 14 | 2 | int:SLIT2 | |
| Interaction | EIF3H interactions | 8.80e-04 | 282 | 14 | 3 | int:EIF3H | |
| Interaction | ACTL6A interactions | 9.45e-04 | 289 | 14 | 3 | int:ACTL6A | |
| Interaction | BICRA interactions | 9.66e-04 | 67 | 14 | 2 | int:BICRA | |
| Interaction | CCNL1 interactions | 9.66e-04 | 67 | 14 | 2 | int:CCNL1 | |
| Interaction | DHX8 interactions | 9.73e-04 | 292 | 14 | 3 | int:DHX8 | |
| Interaction | PNN interactions | 1.07e-03 | 302 | 14 | 3 | int:PNN | |
| Interaction | GPATCH2L interactions | 1.11e-03 | 72 | 14 | 2 | int:GPATCH2L | |
| Interaction | BTBD2 interactions | 1.14e-03 | 73 | 14 | 2 | int:BTBD2 | |
| Interaction | CEP170 interactions | 1.25e-03 | 318 | 14 | 3 | int:CEP170 | |
| Interaction | BCLAF1 interactions | 1.35e-03 | 327 | 14 | 3 | int:BCLAF1 | |
| Interaction | PSENEN interactions | 1.41e-03 | 81 | 14 | 2 | int:PSENEN | |
| Interaction | HEXIM2 interactions | 1.44e-03 | 82 | 14 | 2 | int:HEXIM2 | |
| Interaction | CDKN2A interactions | 1.45e-03 | 335 | 14 | 3 | int:CDKN2A | |
| Interaction | STK11IP interactions | 1.48e-03 | 83 | 14 | 2 | int:STK11IP | |
| Interaction | IRF4 interactions | 1.55e-03 | 85 | 14 | 2 | int:IRF4 | |
| Interaction | CASP1 interactions | 1.58e-03 | 86 | 14 | 2 | int:CASP1 | |
| Interaction | HIRIP3 interactions | 1.62e-03 | 87 | 14 | 2 | int:HIRIP3 | |
| Interaction | HNRNPA0 interactions | 1.63e-03 | 349 | 14 | 3 | int:HNRNPA0 | |
| Interaction | MAGEB2 interactions | 1.63e-03 | 349 | 14 | 3 | int:MAGEB2 | |
| Interaction | POLR1E interactions | 1.64e-03 | 350 | 14 | 3 | int:POLR1E | |
| Interaction | SS18 interactions | 1.66e-03 | 88 | 14 | 2 | int:SS18 | |
| Interaction | SMARCC2 interactions | 1.68e-03 | 353 | 14 | 3 | int:SMARCC2 | |
| Interaction | EIF3A interactions | 1.71e-03 | 355 | 14 | 3 | int:EIF3A | |
| Interaction | PEA15 interactions | 1.73e-03 | 90 | 14 | 2 | int:PEA15 | |
| Interaction | PCGF3 interactions | 1.73e-03 | 90 | 14 | 2 | int:PCGF3 | |
| Interaction | EZH1 interactions | 1.81e-03 | 92 | 14 | 2 | int:EZH1 | |
| Interaction | HNRNPDL interactions | 1.83e-03 | 364 | 14 | 3 | int:HNRNPDL | |
| Interaction | SMARCB1 interactions | 1.83e-03 | 364 | 14 | 3 | int:SMARCB1 | |
| Interaction | GCDH interactions | 1.89e-03 | 94 | 14 | 2 | int:GCDH | |
| Interaction | NR2C2 interactions | 1.91e-03 | 1403 | 14 | 5 | int:NR2C2 | |
| Interaction | DPF3 interactions | 1.93e-03 | 95 | 14 | 2 | int:DPF3 | |
| Interaction | DPF1 interactions | 1.93e-03 | 95 | 14 | 2 | int:DPF1 | |
| Interaction | BPNT1 interactions | 1.97e-03 | 96 | 14 | 2 | int:BPNT1 | |
| Interaction | MPG interactions | 2.05e-03 | 98 | 14 | 2 | int:MPG | |
| Interaction | EIF3CL interactions | 2.05e-03 | 98 | 14 | 2 | int:EIF3CL | |
| Interaction | SS18L1 interactions | 2.05e-03 | 98 | 14 | 2 | int:SS18L1 | |
| Interaction | SMARCC1 interactions | 2.14e-03 | 384 | 14 | 3 | int:SMARCC1 | |
| Interaction | GNL2 interactions | 2.17e-03 | 386 | 14 | 3 | int:GNL2 | |
| Interaction | PCGF5 interactions | 2.18e-03 | 101 | 14 | 2 | int:PCGF5 | |
| Interaction | CCDC12 interactions | 2.31e-03 | 104 | 14 | 2 | int:CCDC12 | |
| Interaction | SAP30BP interactions | 2.35e-03 | 105 | 14 | 2 | int:SAP30BP | |
| Interaction | CCNL2 interactions | 2.39e-03 | 106 | 14 | 2 | int:CCNL2 | |
| Interaction | SMARCD3 interactions | 2.44e-03 | 107 | 14 | 2 | int:SMARCD3 | |
| Interaction | ANKRD50 interactions | 2.48e-03 | 108 | 14 | 2 | int:ANKRD50 | |
| Cytoband | 1p36.33 | 2.49e-04 | 77 | 14 | 2 | 1p36.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 1.78e-02 | 681 | 14 | 2 | chr1p36 | |
| GeneFamily | Cyclin dependent kinases | 5.54e-05 | 26 | 8 | 2 | 496 | |
| GeneFamily | Ankyrin repeat domain containing | 4.74e-03 | 242 | 8 | 2 | 403 | |
| Coexpression | CHIN_BREAST_CANCER_COPY_NUMBER_DN | 2.06e-05 | 13 | 14 | 2 | M8845 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 5.57e-05 | 417 | 14 | 4 | M39224 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 6.39e-05 | 432 | 14 | 4 | M41149 | |
| Coexpression | REICHERT_MITOSIS_LIN9_TARGETS | 9.93e-05 | 28 | 14 | 2 | MM1323 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 1.04e-04 | 177 | 14 | 3 | M39245 | |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 1.63e-04 | 206 | 14 | 3 | M39254 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_GRANULOCYTE_AGEING | 2.09e-04 | 224 | 14 | 3 | MM3836 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | 2.26e-04 | 1144 | 14 | 5 | MM3843 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 2.71e-04 | 46 | 14 | 2 | MM670 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | 3.65e-04 | 680 | 14 | 4 | M41089 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 4.69e-04 | 295 | 14 | 3 | M39121 | |
| Coexpression | AIZARANI_LIVER_C9_LSECS_1 | 5.11e-04 | 304 | 14 | 3 | M39113 | |
| Coexpression | KIM_GERMINAL_CENTER_T_HELPER_UP | 5.24e-04 | 64 | 14 | 2 | M1405 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.62e-06 | 629 | 14 | 6 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 5.33e-06 | 186 | 14 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | 5.79e-06 | 1252 | 14 | 7 | facebase_RNAseq_e10.5_MaxArch_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 5.86e-06 | 432 | 14 | 5 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | 5.95e-06 | 1257 | 14 | 7 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 6.04e-06 | 192 | 14 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 6.04e-06 | 192 | 14 | 4 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 8.74e-06 | 469 | 14 | 5 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | 1.59e-05 | 1459 | 14 | 7 | facebase_RNAseq_e10.5_Emin_LatNas_2500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | 2.19e-05 | 989 | 14 | 6 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.49e-05 | 275 | 14 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.10e-05 | 291 | 14 | 4 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.02e-05 | 311 | 14 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | 7.87e-05 | 1241 | 14 | 6 | facebase_RNAseq_e10.5_MandArch_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.00e-04 | 780 | 14 | 5 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | 1.37e-04 | 1371 | 14 | 6 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.38e-04 | 834 | 14 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | 2.00e-04 | 1468 | 14 | 6 | facebase_RNAseq_e10.5_MandArch_2500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | 2.37e-04 | 492 | 14 | 4 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 2.37e-04 | 492 | 14 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 2.39e-04 | 493 | 14 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 2.48e-04 | 498 | 14 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | 2.97e-04 | 983 | 14 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.20e-04 | 210 | 14 | 3 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | 4.21e-04 | 1060 | 14 | 5 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 4.29e-04 | 232 | 14 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 5.09e-04 | 246 | 14 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 5.65e-04 | 255 | 14 | 3 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.91e-04 | 259 | 14 | 3 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.91e-04 | 259 | 14 | 3 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 6.74e-04 | 271 | 14 | 3 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 6.98e-04 | 654 | 14 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 8.88e-04 | 298 | 14 | 3 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.13e-03 | 744 | 14 | 4 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 1.49e-03 | 801 | 14 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | 1.57e-03 | 1414 | 14 | 5 | facebase_RNAseq_e10.5_Emin_MedNas_2500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.70e-03 | 831 | 14 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 | |
| CoexpressionAtlas | ratio_EmbryoidBody-fibro_vs_EmbryoidBody-derived-from_CD34-iPSC_top-relative-expression-ranked_500_k-means-cluster#3 | 2.08e-03 | 104 | 14 | 2 | ratio_EB-fibro_vs_EB-cbCD34_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 3.09e-03 | 978 | 14 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | 3.17e-03 | 985 | 14 | 4 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 3.22e-03 | 989 | 14 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| CoexpressionAtlas | ratio_EmbryoidBody-blastocyst_vs_EmbryoidBody-fibro_top-relative-expression-ranked_2500_k-means-cluster#1 | 3.26e-03 | 993 | 14 | 4 | ratio_EB-blastocyst_vs_EB-fibro_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | 3.28e-03 | 994 | 14 | 4 | Facebase_RNAseq_e8.5_Floor Plate_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | 3.72e-03 | 492 | 14 | 3 | Facebase_RNAseq_e10.5_Maxillary Arch_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 4.27e-03 | 150 | 14 | 2 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 4.63e-03 | 532 | 14 | 3 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 4.96e-03 | 162 | 14 | 2 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.20e-03 | 166 | 14 | 2 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 5.45e-03 | 564 | 14 | 3 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | 5.78e-03 | 1164 | 14 | 4 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 6.33e-03 | 595 | 14 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | 6.59e-03 | 1208 | 14 | 4 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 6.69e-03 | 607 | 14 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.67e-03 | 203 | 14 | 2 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 8.28e-08 | 138 | 14 | 4 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.45e-07 | 197 | 14 | 4 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.52e-07 | 198 | 14 | 4 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.39e-06 | 135 | 14 | 3 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 187 | 14 | 3 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-05 | 188 | 14 | 3 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 2.69e-05 | 192 | 14 | 3 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 194 | 14 | 3 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.90e-05 | 197 | 14 | 3 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.99e-05 | 199 | 14 | 3 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 2.99e-05 | 199 | 14 | 3 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.99e-05 | 199 | 14 | 3 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.99e-05 | 199 | 14 | 3 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 2.99e-05 | 199 | 14 | 3 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.04e-05 | 200 | 14 | 3 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.04e-05 | 200 | 14 | 3 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_C|E18.5-samps / Age Group, Lineage, Cell class and subclass | 9.92e-04 | 151 | 14 | 2 | 3f2abaa42876ce7a71d934ff16abe0cab0991a05 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.14e-03 | 162 | 14 | 2 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-4|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.20e-03 | 166 | 14 | 2 | 52293b8a74d46e6161fb6a2e7e86e51fd9e89a5b | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.24e-03 | 169 | 14 | 2 | 1c132d21255f5a5174ac38db4e91927f9093418e | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.24e-03 | 169 | 14 | 2 | 5375eb52ebadccb7bfff997a11985f23e81014d6 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.24e-03 | 169 | 14 | 2 | c3bf0cb67f200d02d5a021754e9b2a68d23ea168 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-Tfh|blood / Manually curated celltypes from each tissue | 1.33e-03 | 175 | 14 | 2 | d7e24ac683ff36f7ce3d1151353d3d4a6f2b63bf | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.47e-03 | 184 | 14 | 2 | e6bf826be31e1723e24c366fc5a1cee9b15589bc | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.53e-03 | 188 | 14 | 2 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-03 | 191 | 14 | 2 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-03 | 191 | 14 | 2 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-03 | 191 | 14 | 2 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.58e-03 | 191 | 14 | 2 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.58e-03 | 191 | 14 | 2 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | moderate-Lymphoid-Treg|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.59e-03 | 192 | 14 | 2 | e370ff5aaff7b7042ba9aaf93de43aa563b8b9f9 | |
| ToppCell | IPF-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 1.59e-03 | 192 | 14 | 2 | 356e7a820b744a0ac87352a8d0e6e8d9fa9ed7d2 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-Treg|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.59e-03 | 192 | 14 | 2 | 48d557071bad80edd3ec6e5ad8dcd97037da9553 | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 1.61e-03 | 193 | 14 | 2 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.63e-03 | 194 | 14 | 2 | 8985095f291c1b54e45f4edece49aa26e8c8b732 | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 1.63e-03 | 194 | 14 | 2 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | droplet-Tongue-TONGUE|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-03 | 196 | 14 | 2 | 44a30b1a5f3d8c845e5f3bd17d8102a7449f555b | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-03 | 196 | 14 | 2 | a85f5f1e6acc798e9e02b1a21e0ffe87a323c333 | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.66e-03 | 196 | 14 | 2 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | 3'|World / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.66e-03 | 196 | 14 | 2 | 44007f0c14e0f0703f7ee715b8eababb4d80a8b5 | |
| ToppCell | droplet-Tongue-TONGUE-1m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-03 | 196 | 14 | 2 | 9935bdb10789e8cfc922dca526ca3bf8317fe270 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.68e-03 | 197 | 14 | 2 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.69e-03 | 198 | 14 | 2 | 1847ce8c344c8a3e50f3cbbf758a38aba69f85b0 | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 1.69e-03 | 198 | 14 | 2 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.69e-03 | 198 | 14 | 2 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | moderate-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.69e-03 | 198 | 14 | 2 | 0a868098b1ee4b28b2149ed766acb09e9c0ce14c | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 1.69e-03 | 198 | 14 | 2 | 6333e46cd1ccf5841ce15aea98a4b2f5e3ae4675 | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 1.69e-03 | 198 | 14 | 2 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.69e-03 | 198 | 14 | 2 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.71e-03 | 199 | 14 | 2 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.71e-03 | 199 | 14 | 2 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.71e-03 | 199 | 14 | 2 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-NK_CD56bright|Influenza_Severe / Disease, condition lineage and cell class | 1.71e-03 | 199 | 14 | 2 | 784e7e7ede2baa28ede600834813e6de2240bfdf | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Trm_Th1/Th17|GI_small-bowel / Manually curated celltypes from each tissue | 1.71e-03 | 199 | 14 | 2 | 508a6efc11b1b45899a968888865731088cac668 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 1.71e-03 | 199 | 14 | 2 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.71e-03 | 199 | 14 | 2 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 1.73e-03 | 200 | 14 | 2 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 1.73e-03 | 200 | 14 | 2 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.75e-03 | 195 | 14 | 2 | DOID:1574 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KHKHSSEEDKDKKHK | 56 | Q13523 | |
| SEEDKDKKHKHKHKH | 61 | Q13523 | |
| FKEKKDTKEKHKDTH | 1056 | Q6UB99 | |
| DKNDHDKHKDRKRKK | 51 | Q9NPI1 | |
| SDHERERHKEKKKKK | 56 | Q9H8M2 | |
| KAHHRKDEKRKEKRR | 96 | P21127 | |
| KKHKLKHKEREKEKH | 651 | Q6UB98 | |
| KHKKEKKKKDKEHRR | 196 | Q9BU76 | |
| KRKEHKEAHQKAREK | 466 | P46199 | |
| KEKLKEKHREAEKSH | 101 | Q8WVS4 | |
| KNKDKHKAKKEHRRK | 856 | Q9BRR8 | |
| KVHHRKDEKRKEKWK | 96 | Q9UQ88 | |
| HHKKKKRAKRKEREE | 816 | Q6ZW05 | |
| KKRKRQEEKHVCKKH | 86 | Q5EBN2 | |
| RHRDDKRDSKKEKKH | 411 | Q5VTL8 | |
| HKKKKKKRKHSEEAE | 306 | Q3B726 | |
| DKHKDREHRHKEHKK | 26 | P11387 | |
| KEHKKEKDREKSKHS | 36 | P11387 | |
| KHKDKHKDRDKEKRK | 76 | P11387 |